Quaker Wealth Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$51.3K Hold
1,065
– – 0.02% 165
2026
Q2
$55.8K Buy
1,065
+200
+23% +$10.6K 0.02% 159
2026
Q1
$47.7K Sell
865
-42
-5% -$2.28K 0.01% 167
2025
Q4
$44.5K Buy
907
+42
+5% +$1.96K 0.01% 179
2025
Q3
$37.3K Hold
865
– – 0.01% 190
2025
Q2
$33.2K Buy
+865
New +$33.1K 0.01% 206
2020
Q4
– Sell
-4,240
Closed -$200K – 50
2020
Q3
$200K Buy
4,240
+49
+1% +$2.46K 0.11% 47
2020
Q2
$214K Buy
+4,191
New +$215K 0.13% 45

Other funds holding GSK

Quaker Wealth Management's GSK Position: Q3 2026 in Review

Quaker Wealth Management held its GSK (GSK) position steady in Q3 2026 at 1,065 shares worth $51.3K. The position accounts for 0.02% of the portfolio, ranked #165.

Quaker Wealth Management first reported a position in GSK in Q2 2020 and has held it in 8 quarters since. The position peaked at $214K in Q2 2020. 460 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Quaker Wealth Management held 1,065 shares of GSK worth $51.3K as of Q3 2026.
  • Quaker Wealth Management left its GSK share count unchanged in Q3 2026.
  • GSK made up 0.02% of Quaker Wealth Management's portfolio in Q3 2026, its #165 holding.
  • Quaker Wealth Management first reported a position in GSK in Q2 2020 and has held it in 8 quarters since.
  • Quaker Wealth Management's GSK position peaked at $214K in Q2 2020.
  • 460 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.